LSP-249
LSP-249 is a potent small molecule inhibitor of plasma kallikrein, exhibiting an EC50 below 100 nM in cellular assays. It is a valuable research tool for investigating hereditary angioedema (HAE) pathophysiology and for preclinical in vitro and in vivo studies targeting kallikrein-mediated pathways.
Product Specifications
CAS Number
1801253-04-2
Product Name Alternative
Angioedema, LSP 249, LSP249, LSP-249, Inhibitor, kallikrein, kallikrein in cell, inhibit, Threonine proteases, Serine proteases, Ser/Thr Protease, Serine endopeptidases
Field of Research
Protein Biochemistry
Purity
99.27% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.63 mM) ; DMSO:31.25 mg/mL (72.35 mM)
Smiles
Cc1cc (N) nc (C) c1CNC (=O) c1ccnc (Cc2ccc3ncc (Cl) cc3c2) c1
Molecular Formula
C24H22ClN5O
Molecular Weight
431.92
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A135483 100 µL
Obrindatamab Biosimilar (Monoclonal, scFv with Domain Crossover, Kappa; Lambda)
Sign In for Pricing
View Details 